Episode 134 | David Narrow, CEO at Sonavex | Commercial Strategy: Reimbursement, Limited Release, and Stakeholder Analysis

from Project Medtech · host Project Medtech

In this episode, David Narrow and Duane Mancini discuss the stagnant innovation in dialysis, reimbursement strategy, the strategy behind a limited market release, identifying various stakeholders and how they are incentivized, the importance of building your team, licensing from an University, and so much more. David Narrow LinkedIn Sonavex Website Project Medtech Website Project Medtech LinkedIn Duane Mancini LinkedIn

Episode metadata supplied by the publisher feed · Published Apr 10, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 134 | David Narrow, CEO at Sonavex | Commercial Strategy: Reimbursement, Limited Release, and Stakeholder Analysis

0:00 51:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Project Medtech?

This episode is 51 minutes long.

When was this Project Medtech episode published?

This episode was published on April 10, 2023.

Can I download this Project Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!